Giant cell arteritis: immune and vascular aging as disease risk factors Full Text
Arthritis Research & Therapy, 08/24/2011

1 Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol Arthritis & Rheumatism, April 16, 2012    Clinical Article

2 Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis International Journal of Clinical Practice, April 5, 2012    Evidence Based Medicine    Clinical Article

3 A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone Arthritis & Rheumatism, April 24, 2012    Clinical Article

4 The Role of Antidepressants in the Management of Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis CNS Drugs, April 4, 2012    Evidence Based Medicine    Clinical Article

5 Effects of Double Filtration Plasmapheresis, Leflunomide, and Methotrexate on Inflammatory Changes Found Through Magnetic Resonance Imaging in Early Rheumatoid Arthritis Journal of Rheumatology, April 19, 2012    Clinical Article

6 Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial The Lancet - Early Online Publication, April 16, 2012

7 A Prospective Observational Study of Mycophenolate Mofetil Treatment in Progressive Diffuse Cutaneous Systemic Sclerosis of Recent Onset Journal of Rheumatology, April 5, 2012

8 A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early, aggressive rheumatoid arthritis Arthritis & Rheumatism, April 30, 2012    Clinical Article

9 Predicting future response to certolizumab pegol in rheumatoid arthritis patients: Features at 12 weeks associated with low disease activity at 1 year Arthritis Care and Research , April 18, 2012    Clinical Article

10 Rheumatoid Arthritis Disease Activity Measures: American College of Rheumatology Recommendations for Use in Clinical Practice Arthritis Care and Research , April 6, 2012

11 Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation Full Text International Journal of Women's Health, April 13, 2012    Free full text    Clinical Article

12 Indirect Treatment Comparison of Abatacept with Methotrexate Versus Other Biologic Agents for Active Rheumatoid Arthritis Despite Methotrexate Therapy in the United Kingdom Journal of Rheumatology, April 23, 2012    Clinical Article

13 Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus Arthritis Care and Research , April 9, 2012

14 A Single Dose of Indomethacin Does Not Prolong Premotor Reaction Time in Young, Healthy Adults: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study Rheumatism, April 13, 2012    Clinical Article

15 Bone mineral density in asthmatic patients on inhaled corticosteroids in a developing country Full Text Annals of Thoracic Medicine, April 3, 2012    Free full text    Clinical Article

16 Golimumab, a human TNF-alpha antibody, administered every 4 weeks as a subcutaneous injection in psoriatic arthritis: Clinical efficacy, radiographic, and safety findings through 1year of the randomized, placebo-controlled, GO-REVEAL study Arthritis & Rheumatism, April 23, 2012    Clinical Article

17 Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial Annals of Internal Medicine, March 15, 2012    Clinical Article

18 Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The Lupus Nephritis Assessment with Rituximab study Arthritis & Rheumatism, April 30, 2012    Clinical Article

19 The efficacy and safety of febuxostat for urate lowering in gout patients [greater than or equal to]65 years of age Full Text BMC Geriatrics, March 27, 2012    Free full text    Clinical Article

20 Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160 Annals of Rheumatic Diseases, April 11, 2012